These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 31978378)

  • 21. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.
    Corbin JD; Francis SH; Webb DJ
    Urology; 2002 Sep; 60(2 Suppl 2):4-11. PubMed ID: 12414329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors.
    Rabal O; Sánchez-Arias JA; Cuadrado-Tejedor M; de Miguel I; Pérez-González M; García-Barroso C; Ugarte A; Estella-Hermoso de Mendoza A; Sáez E; Espelosin M; Ursua S; Haizhong T; Wei W; Musheng X; Garcia-Osta A; Oyarzabal J
    ACS Chem Neurosci; 2019 Mar; 10(3):1765-1782. PubMed ID: 30525452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
    Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
    Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marked disparity of microRNA modulation by cGMP-selective PDE5 versus PDE9 inhibitors in heart disease.
    Kokkonen-Simon KM; Saberi A; Nakamura T; Ranek MJ; Zhu G; Bedja D; Kuhn M; Halushka MK; Lee DI; Kass DA
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8
    Jin S; Xiang P; Liu J; Yang Y; Hu S; Sheng J; He Q; Yu W; Han W; Jin J; Peng J
    Prostate; 2019 Jun; 79(8):909-919. PubMed ID: 30958912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer's disease.
    Tropea MR; Gulisano W; Vacanti V; Arancio O; Puzzo D; Palmeri A
    Free Radic Biol Med; 2022 Nov; 193(Pt 2):657-668. PubMed ID: 36400326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.
    Puzzo D; Vitolo O; Trinchese F; Jacob JP; Palmeri A; Arancio O
    J Neurosci; 2005 Jul; 25(29):6887-97. PubMed ID: 16033898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's Disease.
    Fiorito J; Vendome J; Saeed F; Staniszewski A; Zhang H; Yan S; Deng SX; Arancio O; Landry DW
    J Med Chem; 2017 Nov; 60(21):8858-8875. PubMed ID: 28985058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice.
    Lueptow LM; Zhan CG; O'Donnell JM
    Psychopharmacology (Berl); 2016 Feb; 233(3):447-56. PubMed ID: 26525565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PDE5 modulates oocyte spontaneous maturation via cGMP-cAMP but not cGMP-PKG signaling.
    Wang S; Ning G; Chen X; Yang J; Ouyang H; Zhang H; Tai P; Mu X; Zhou B; Zhang M; Xia G
    Front Biosci; 2008 May; 13():7087-95. PubMed ID: 18508718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
    Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D
    J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of PDE5 Inhibitors and the NO/cGMP Pathway in Cancer.
    Peak TC; Richman A; Gur S; Yafi FA; Hellstrom WJ
    Sex Med Rev; 2016 Jan; 4(1):74-84. PubMed ID: 27872007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist.
    Ribaudo G; Ongaro A; Zagotto G; Memo M; Gianoncelli A
    ACS Chem Neurosci; 2020 Jun; 11(12):1726-1739. PubMed ID: 32401481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation.
    Mullershausen F; Russwurm M; Koesling D; Friebe A
    Mol Biol Cell; 2004 Sep; 15(9):4023-30. PubMed ID: 15240816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade.
    Acquarone E; Argyrousi EK; van den Berg M; Gulisano W; Fà M; Staniszewski A; Calcagno E; Zuccarello E; D'Adamio L; Deng SX; Puzzo D; Arancio O; Fiorito J
    Mol Neurodegener; 2019 Jun; 14(1):26. PubMed ID: 31248451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels.
    Gómez-Vallejo V; Ugarte A; García-Barroso C; Cuadrado-Tejedor M; Szczupak B; Dopeso-Reyes IG; Lanciego JL; García-Osta A; Llop J; Oyarzabal J; Franco R
    J Neurochem; 2016 Jan; 136(2):403-15. PubMed ID: 26641206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
    Thieme M; Sivritas SH; Mergia E; Potthoff SA; Yang G; Hering L; Grave K; Hoch H; Rump LC; Stegbauer J
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F474-F481. PubMed ID: 28052870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic GMP-dependent signaling in cardiac myocytes.
    Takimoto E
    Circ J; 2012; 76(8):1819-25. PubMed ID: 22785374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.
    Shimizu-Albergine M; Rybalkin SD; Rybalkina IG; Feil R; Wolfsgruber W; Hofmann F; Beavo JA
    J Neurosci; 2003 Jul; 23(16):6452-9. PubMed ID: 12878685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of phosphodiesterase 5 reduces bone mass by suppression of canonical Wnt signaling.
    Gong Y; Xu CY; Wang JR; Hu XH; Hong D; Ji X; Shi W; Chen HX; Wang HB; Wu XM
    Cell Death Dis; 2014 Nov; 5(11):e1544. PubMed ID: 25429621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.